{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:01:56Z","timestamp":1774263716254,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["neurotox res"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/bf03033933","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T17:58:17Z","timestamp":1248112697000},"page":"145-148","source":"Crossref","is-referenced-by-count":54,"title":["Botulinum toxin therapy for cervical dystonia"],"prefix":"10.1007","volume":"9","author":[{"given":"Joseph","family":"Jankovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,7]]},"reference":[{"key":"BF03033933_CR1","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1212\/01.WNL.0000163767.99354.C3","volume":"64","author":"R Benecke","year":"2005","unstructured":"Benecke R, WH Jost, P Kanovsky, E Ruzicka, G Comes and S Grafe (2005) A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia.Neurology 64, 1949\u20131951.","journal-title":"Neurology"},{"key":"BF03033933_CR2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/mds.20290","volume":"20","author":"B Berman","year":"2005","unstructured":"Berman B, L Seeberger and R Kumar (2005) Long-term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia.Mov. Disord. 20, 233\u2013237.","journal-title":"Mov. Disord."},{"issue":"Suppl. 5","key":"BF03033933_CR3","first-page":"A511","volume":"62","author":"CL Comella","year":"2004","unstructured":"Comella CL, J Jankovic, S Daggett, J Mordaunt and MF Brin (2004) Interim results of an observational study of neutralizing antibody formation with the current preparation of botulinum toxin type A treatment for cervical dystonia.Neurology 62 (Suppl. 5), A511.","journal-title":"Neurology"},{"key":"BF03033933_CR4","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1212\/01.wnl.0000183055.81056.5c","volume":"65","author":"CL Comella","year":"2005","unstructured":"Comella CL, J Jankovic, KM Shannon, J Tsui, M Swenson, S Leurgans and W Fan Dystonia Study Group (2005) Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia.Neurology 65, 1423\u20131429.","journal-title":"Neurology"},{"key":"BF03033933_CR5","first-page":"211","volume-title":"Therapy with Botulinum Toxin","author":"ES Consky","year":"1994","unstructured":"Consky ES and AE Lang (1994) Clinical assessments of patients with cervical dystonia, In:Therapy with Botulinum Toxin (Jankovic J and M Hallett, Eds.) (Marcel Dekker: New York, NY),pp 211\u2013237."},{"key":"BF03033933_CR6","doi-asserted-by":"crossref","unstructured":"Diamond A, J Shahed, S Azher, K Dat-Vuong, R Simpson and J Jankovic (2005) Globus pallidus deep brain stimulation in dystonia.Mov. Disord. 2005 Dec 9; [Epub ahead of print].","DOI":"10.1002\/mds.20767"},{"key":"BF03033933_CR7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000067023","volume":"49","author":"D Dressler","year":"2003","unstructured":"Dressler D and R Benecke (2003) Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis.Eur. Neurol. 49, 34\u201338.","journal-title":"Eur. Neurol."},{"key":"BF03033933_CR8","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s00415-005-0774-3","volume":"252","author":"D Dressler","year":"2005","unstructured":"Dressler D and H Bigalke (2005) Botulinum toxin type Bde novo therapy of cervical dystonia: frequency of antibody induced therapy failure.J. Neurol. 252, 904\u2013907.","journal-title":"J. Neurol."},{"key":"BF03033933_CR9","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/mds.20625","volume":"20","author":"D Dressler","year":"2005","unstructured":"Dressler D, M Lange and H Bigalke (2005) Mouse diaphragm assay for detection of antibodies against botulinum toxin type B.Mov. Disord. 20, 1617\u20131619.","journal-title":"Mov. Disord."},{"key":"BF03033933_CR10","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/jnnp.73.4.406","volume":"73","author":"C Ertekin","year":"2002","unstructured":"Ertekin C, I Aydogdu, Y Secil, N Kiylioglu, S Tarlaci and T Ozdemirkiran (2002) Oropharyngeal swallowing in craniocervi-cal dystonia.J. Neurol. Neurosurg. Psychiatry 73, 406\u2013411.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BF03033933_CR11","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/mds.20531","volume":"20","author":"SA Factor","year":"2005","unstructured":"Factor SA, ES Molho, S Evans and PJ Feustel (2005) Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia.Mov. Disord. 20, 1152\u20131160.","journal-title":"Mov. Disord."},{"issue":"Suppl. 8","key":"BF03033933_CR12","doi-asserted-by":"crossref","first-page":"S109A","DOI":"10.1002\/mds.20024","volume":"19","author":"J Jankovic","year":"2004","unstructured":"Jankovic J (2004a) Treatment of cervical dystonia with botulinum toxin.Mov. Disord. 19 (Suppl. 8), S109A-S115A.","journal-title":"Mov. Disord."},{"key":"BF03033933_CR13","doi-asserted-by":"crossref","first-page":"951b","DOI":"10.1136\/jnnp.2003.034702","volume":"75","author":"J Jankovic","year":"2004","unstructured":"Jankovic J (2004b) Botulinum toxin in clinical practice.J. Neurol. Neurosurg. Psychiatry 75, 951b-957b.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BF03033933_CR14","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1212\/01.WNL.0000055087.96356.BB","volume":"60","author":"J Jankovic","year":"2003","unstructured":"Jankovic J, KD Vuong and J Ahsan (2003) Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia.Neurology 60, 1186\u20131188.","journal-title":"Neurology"},{"key":"BF03033933_CR15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/01.wnf.0000145508.84389.87","volume":"27","author":"J Jankovic","year":"2004","unstructured":"Jankovic J, A Esquenazi, D Fehling, F Freitag, AM Lang and M Naumann (2004) Evidence-based review of patient reported outcomes with botulinum toxin type A.Clin. Neuropharmacol. 27, 234\u2013244.","journal-title":"Clin. Neuropharmacol."},{"issue":"Suppl. 10","key":"BF03033933_CR16","first-page":"S22a","volume":"20","author":"J Jankovic","year":"2005","unstructured":"Jankovic J, J Tsui and C Bergeron (2005a) Prevalence of cervical dystonia and spasmodic torticollis in the United States.Mov. Disord. 20 (Suppl. 10) S22a.","journal-title":"Mov. Disord."},{"issue":"Suppl. 9","key":"BF03033933_CR17","first-page":"S54","volume":"58","author":"J Jankovic","year":"2005","unstructured":"Jankovic J, CB Hunter and the BOS Study Group (2005b) Botulinum toxin type B observational study.Ann. Neurol. 58 (Suppl. 9) S54.","journal-title":"Ann. Neurol."},{"key":"BF03033933_CR18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/mds.20468","volume":"20","author":"A Marchetti","year":"2005","unstructured":"Marchetti A, R Magar, L Findley, JP Larsen, Z Pirtosek, E Ruzicka, R Jech, J Slawek and F Ahmed (2005) Retrospective evaluation of the dose of Dysport\u00ae and BOTOX\u00ae in the management of cervical dystonia and blepharospasm: The REAL DOSE study.Mov. Disord. 20, 937\u2013944.","journal-title":"Mov. Disord."},{"key":"BF03033933_CR19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/mds.20376","volume":"20","author":"NI Mejia","year":"2005","unstructured":"Mejia NI, KD Vuong and J Jankovic (2005) Long-term botulinum toxin efficacy, safety and immunogenicity.Mov. Disord. 20, 592\u2013597.","journal-title":"Mov. Disord."},{"key":"BF03033933_CR20","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1185\/030079904125003962","volume":"20","author":"M Naumann","year":"2004","unstructured":"Naumann M and J Jankovic (2004) Safety of botulinum toxin type A: a systematic review and meta-analysis.Curr. Med. Res. Opin. 20, 981\u2013990.","journal-title":"Curr. Med. Res. Opin."},{"key":"BF03033933_CR21","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1212\/WNL.40.9.1443","volume":"40","author":"JE Riski","year":"1990","unstructured":"Riski JE, J Horner and BS Nashold Jr (1990) Swallowing function in patients with spasmodic torticollis.Neurology 40, 1443\u20131445.","journal-title":"Neurology"},{"key":"BF03033933_CR22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1212\/01.wnl.0000174433.76707.8c","volume":"65","author":"R Tintner","year":"2005","unstructured":"Tintner R, R Gross, UF Winzer, KA Smalky and J Jankovic (2005) Autonomic function after botulinum toxin type A or B: a double-blind, randomized trial.Neurology 65, 765\u2013767.","journal-title":"Neurology"},{"key":"BF03033933_CR23","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/mds.20403","volume":"20","author":"D Truong","year":"2005","unstructured":"Truong D, DD Duane, J Jankovic, C Singer, LC Seeberger, CL Comella, MF Lew, RL Rodnitzky, FO Danisi, JP Sutton, PD Charles, RA Hauser and GL Sheean (2005) Efficacy and safety of botulinum type A toxin (Dysport\u00ae) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.Mov. Disord. 20, 783\u2013791.","journal-title":"Mov. Disord."},{"key":"BF03033933_CR24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa042187","volume":"352","author":"M Vidailhet","year":"2005","unstructured":"Vidailhet M, L Vercueil, JL Houeto, P Krystkowiak, AL Benabid, P Cornu, C Lagrange, S Tezenas du Montcel, D Dormont, S Grand, S Blond, O Detante, B Pillon, C Ardouin, Y Agid, A Destee, P Pollak and the French Stimulation du Pallidum Interne dans la Dystonie (SPIDY) Study Group (2005) Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia.N. Engl. J. Med. 352, 459\u2013467.","journal-title":"N. Engl. J. Med."}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033933.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03033933\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T02:11:09Z","timestamp":1685067069000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03033933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":24,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["BF03033933"],"URL":"https:\/\/doi.org\/10.1007\/bf03033933","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}